Health Catalyst, Inc. (NASDAQ:HCAT) Shares Sold by Jane Street Group LLC

Jane Street Group LLC cut its stake in shares of Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 67.4% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 49,477 shares of the company's stock after selling 102,244 shares during the period. Jane Street Group LLC owned about 0.08% of Health Catalyst worth $350,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in the stock. First Light Asset Management LLC raised its position in Health Catalyst by 22.0% during the fourth quarter. First Light Asset Management LLC now owns 5,241,121 shares of the company's stock worth $37,055,000 after acquiring an additional 944,631 shares during the period. Northern Trust Corp raised its position in Health Catalyst by 8.5% during the fourth quarter. Northern Trust Corp now owns 526,607 shares of the company's stock worth $3,723,000 after acquiring an additional 41,298 shares during the period. Aquatic Capital Management LLC acquired a new position in Health Catalyst during the fourth quarter worth $63,000. Susquehanna Fundamental Investments LLC acquired a new position in Health Catalyst during the fourth quarter worth $806,000. Finally, Two Sigma Securities LLC raised its position in Health Catalyst by 19.5% during the fourth quarter. Two Sigma Securities LLC now owns 17,510 shares of the company's stock worth $124,000 after acquiring an additional 2,862 shares during the period. 85.00% of the stock is currently owned by institutional investors and hedge funds.

Health Catalyst Trading Down 2.8%

Shares of HCAT traded down $0.11 during mid-day trading on Thursday, reaching $3.84. The stock had a trading volume of 260,705 shares, compared to its average volume of 596,273. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.41 and a quick ratio of 1.41. Health Catalyst, Inc. has a 52-week low of $3.49 and a 52-week high of $9.24. The business's fifty day moving average is $3.96 and its 200 day moving average is $5.42. The firm has a market cap of $267.27 million, a price-to-earnings ratio of -2.84 and a beta of 1.56.

Analyst Ratings Changes

HCAT has been the subject of a number of research analyst reports. Canaccord Genuity Group reduced their price objective on shares of Health Catalyst from $10.00 to $9.00 and set a "buy" rating for the company in a research report on Thursday, May 8th. Stifel Nicolaus upped their price objective on shares of Health Catalyst from $5.00 to $5.50 and gave the stock a "hold" rating in a research report on Thursday, May 8th. Royal Bank of Canada reduced their target price on shares of Health Catalyst from $7.00 to $6.00 and set a "sector perform" rating for the company in a research report on Thursday, February 27th. Evercore ISI cut shares of Health Catalyst from an "outperform" rating to an "inline" rating in a research report on Wednesday, April 9th. Finally, Stephens reduced their target price on shares of Health Catalyst from $7.00 to $5.00 and set an "equal weight" rating for the company in a research report on Thursday, March 6th. Three research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $8.00.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.